Literature DB >> 18941886

Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist.

Mustafa Bahceci1, Ulun Ulug.   

Abstract

PURPOSE: This study evaluated the impact of route of progesterone administration as luteal phase support on the outcome of assisted conception cycles.
METHODS: Intramuscular progesterone in oil (IMP) at 100 mg daily was administered to 903 women following oocyte retrieval whereas vaginal progesterone gel (VMP) at 90 mg was administered twice daily to 1,110 women. Retrospective analysis was performed according to the type of GnRH analogue used. Implantation (IR), clinical pregnancy (CPR) and biochemical pregnancy rates (BPR) were main outcomes.
RESULTS: In GnRH agonist cycles, neither IR, CPR or BPR differed according to the route of progesterone. However, in GnRH antagonist cycles, IR and CPR were significantly lower in VMP group compared to IMP group. BPR also was significantly higher in VMP group compared to IMP group.
CONCLUSION: Our results suggest that route of progesterone administration for luteal phase support can be an important prognostic factor according to the type of GnRH analogue used for controlled ovarian hyperstimulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941886      PMCID: PMC2582092          DOI: 10.1007/s10815-008-9269-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  21 in total

1.  Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers.

Authors:  H Levine
Journal:  Fertil Steril       Date:  2000-10       Impact factor: 7.329

2.  Experience with progesterone gel for luteal support in a highly successful IVF programme.

Authors:  W B Schoolcraft; J S Hesla; M J Gee
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

Review 3.  The luteal phase after ovarian stimulation.

Authors:  Efstratios M Kolibianakis; Paul Devroey
Journal:  Reprod Biomed Online       Date:  2002       Impact factor: 3.828

Review 4.  Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.

Authors:  E A Pritts; A K Atwood
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

Review 5.  Luteal phase support.

Authors:  Alan S Penzias
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

6.  A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.

Authors:  A M Propst; J A Hill; E S Ginsburg; S Hurwitz; J Politch; E H Yanushpolsky
Journal:  Fertil Steril       Date:  2001-12       Impact factor: 7.329

7.  Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.

Authors:  S J Chantilis; K M Zeitoun; S I Patel; D A Johns; V A Madziar; D D McIntire
Journal:  Fertil Steril       Date:  1999-11       Impact factor: 7.329

8.  Luteal support with vaginal micronized progesterone gel in assisted reproduction.

Authors:  Alan S Penzias; Michael M Alper
Journal:  Reprod Biomed Online       Date:  2003 Apr-May       Impact factor: 3.828

Review 9.  Luteal phase support in assisted reproduction cycles.

Authors:  S Daya; J Gunby
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Direct transport of progesterone from vagina to uterus.

Authors:  E Cicinelli; D de Ziegler; C Bulletti; M G Matteo; L M Schonauer; P Galantino
Journal:  Obstet Gynecol       Date:  2000-03       Impact factor: 7.661

View more
  1 in total

1.  Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates.

Authors:  Salwa Gari; Dania Al-Jaroudi
Journal:  JBRA Assist Reprod       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.